Efficacy and Safety of Temozolomide in Metastatic Melanoma Patients Previously Treated with Immunotherapy and Targeted Therapy
Background: Metastatic melanoma remains a significant challenge in oncology, particularly for patients exhibiting disease progression despite innovative treatments such as immunotherapy and targeted therapy. The development of alternative therapeutic strategies is crucial for improving outcomes in this patient population.
Authors
- Ivona Jovanoska
- Milena Ivanova (ORCID: https://orcid.org/0000-0003-4128-9915)
- Igor Stojkovski (ORCID: https://orcid.org/0000-0002-5770-2578)
- K. Jovevski
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100626
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00